The
TEAD transcription factors are the most distal elements of
the Hippo pathway, and their transcriptional activity is regulated
by several proteins, including YAP. In some cancers, the Hippo pathway
is deregulated and inhibitors of the YAP:TEAD interaction are foreseen
as new anticancer drugs. The binding of YAP to TEAD is driven by the
interaction of an α-helix and an Ω-loop present in its
TEAD-binding domain with two distinct pockets at the TEAD surface.
Using the mRNA-based display technique to screen a library of in vitro-translated cyclic peptides, we identified a peptide
that binds with a nanomolar affinity to TEAD. The X-ray structure
of this peptide in complex with TEAD reveals that it interacts with
the α-helix pocket. Under our experimental conditions, this
peptide can form a ternary complex with TEAD and YAP. Furthermore,
combining it with a peptide binding to the Ω-loop pocket gives
an additive inhibitory effect on the YAP:TEAD interaction. Overall,
our results show that it is possible to identify nanomolar inhibitors
of the YAP:TEAD interaction that bind to the α-helix pocket,
suggesting that developing such compounds might be a strategy to treat
cancers where the Hippo pathway is deregulated.